参考文献/References:
［1］中华医学会风湿病医学分会.抗磷脂抗体综合征诊断和治疗指南 ［J］.中华风湿病学杂志,2011,15（6）：407410.
［2］Islam MA, Alam F, Gan SH, et al. A 15year single center retrospective study of antiphospholipid syndrome patients from Northern Malaysia ［J］.Malays J Pathol,2017,39(2):123133.
［3］Pengo V, Testa S, Martinelli I, et al. Incidence of a first thromboembolic event in carriers of isolated lupus anticoagulant［J］. Thromb Res, 2015, 135(1):4649.
［4］Ruffatti A, Tonello M, Cavazzana A, et al. Laboratory classification categories and pregnancy outcome in patients with primary antiphospholipid syndrome prescribed antithrombotic therapy［J］.Thromb Res, 2009,123(3):482487.
［5］Ruffatti A, Olivieri S, Tonello M, et al. Influence of different IgG anticardiolipin antibody cutoff values on antiphospholipid syndrome classification ［J］.J Thromb Haemost,2008,6(10):16931696.
［6］尹红亚,辛虹.抗磷脂抗体与子痫前期关系的Meta分析 ［J］.现代妇产科进展，2010,19(11):823828.
［7］岑倩丽.抗磷脂综合征病理妊娠的机制与治疗进展 ［J］.辽宁医学杂志,2015,29(5):286287.
［8］Meroni PL, Raschi E, Grossi C, et al. Obstetric and vascular APS: same autoantibodies but different diseases?［J］. Lupus,2012,21(7):708710.
［9］林其德.复发性流产免疫学诊断及诊疗共识 ［J］.生殖医学杂志,2008,17(1):45.
［10］AbuHeija A. Thrombophilia and recurrent pregnancy loss: Is heparin still the drug of choice ［J］.Sultan Qaboos Univ Med J, 2014,14(1):e 2636.
［11］Keeling D, Mackie I, Moore GW, et al. Guidelines on the investigation and management of antiphospholipid syndrome ［J］. Br J Haematol, 2012 ,157(1):4758.
［12］Ricci G, Giolo E, Simeone R. Heparin's potential to improve pregnancy rates and outcomes is not evidencebased ［J］. Hum Reprod Update,2010,16(2):225227．
［13］低分子肝素防治自然流产中国专家共识编写组.低分子肝素防治自然流产中国专家共识 ［J］.中华生殖与避孕杂志,2018,38(9):701708.
［14］Kravvariti E, Koutsogianni A, Samoli E, et al.The effect of hydroxychloroquine on thrombosis prevention and antiphospholipid antibody levels in primary antiphospholipidsyndrome: A pilot open label randomized prospective study ［J］.Autoimmun Rev, 2020,19(4):102491.
［15］Mekinian A, CostedoatChalumeau N, Masseau A, et al. Obstetrical APS: is there a place for hydroxychloroquine to improve the pregnancy outcome ［J］.Autoimmun Rev, 2015,14(1):2329.
［16］严凤亭,李大金,孙晓溪,等.环孢素A对正常早孕期细胞滋养细胞体外生长的调节作用 ［J］.中华妇产科学杂志,2002,37(2):1315,68.
［17］Sivaraman P. Management of pregnancy in transplant recipients ［J］. Transplant Proc, 2004 , 36(7):19992000.
［18］Nulman I, Sgro M, Barrera M, et al. Longterm neurodevelopment of children exposed in utero to ciclosporin after maternal renal transplant ［J］.Paediatr Drugs, 2010, 12(2):113122.
［19］Azizi R, Ahmadi M, Danaii S,et al.Cyclosporine A improves pregnancy outcomes in women with recurrent pregnancy loss and elevated Th 1/Th 2 ratio ［J］.J Cell Physiol,2019,234(10):1903919047.
［20］Alami Z, Agier MS, Ahid S,et al. Pregnancy outcome following in utero exposure to azathioprine: A French comparative observational study ［J］. Therapie,2018,73(3):199207.
［21］Chan JKH, Harris EN, Hughes GRV. Successful pregnancy following suppression of anticardiolipin antibody and lupus anticoagulant with azathioprine in systemic lupus erythematosus［J］.J Obstet Gynaecol. 1986,7(1):1617.
［22］Saavedra M, Sánchez A, Morales S,et al. Azathioprine during pregnancy in systemic lupus erythematosus patients is not associated with poor fetal outcome ［J］.Clin Rheumatol, 2015,34(7):12111216.
［23］Plauborg AV, Hansen AV, Garne E.Use of azathioprine and corticosteroids during pregnancy and birth outcome in women diagnosed with inflammatory bowel disease ［J］. Birth Defects Res A Clin Mol Teratol, 2016,106(6):494499.
［24］ Ichinose K,Sato S,Kitajima Y,et al. The efficacy of adjunct tacrolimus treatment in pregnancy outcomes in patients with systemic lupus erythematosus［J］. Lupus,2018,27(8):13121320.
［25］ Nakagawa K, KwakKim J, Hisano M,et al. Obstetric and perinatal outcome of the women with repeated implantation failures or recurrent pregnancy losses who received pre and postconception tacrolimus treatment［J］. Am J Reprod Immunol, 2019,82(2):e 13142.
相似文献/References:
[1]雷贞武.各种先天性子宫异常与复发性流产的临床问题[J].中国计划生育和妇产科,2009,(06):0.
[2]万波,颜友良,胡文娟,等.心理干预与复发性流产妊娠结局的研讨[J].中国计划生育和妇产科,2013,(01):0.
WAN Bo,YAN You-liang*,HU Wen-juan,et al.[J].Chinese Journal of Family Planning & Gynecotokology,2013,(5):0.
[3]李树侠,张弘,陈昕,等.宫腔镜检查在复发性流产患者诊治中的作用[J].中国计划生育和妇产科,2013,(05):0.
LI Shu-xia,ZHANG Hong,CHEN Xin,et al.[J].Chinese Journal of Family Planning & Gynecotokology,2013,(5):0.
[4]庞小艳,邓小清,肖翠艳,等.复发性流产患者清宫术中个性化护理的临床观察[J].中国计划生育和妇产科,2014,(08):0.
PANG Xiao-yan,DENG Xiao-qing,XIAO Cui-yan,et al.[J].Chinese Journal of Family Planning & Gynecotokology,2014,(5):0.
[5]廖红玉.阿司匹林联合地塞米松孕前干预D2聚体升高型复发性流产的疗效分析[J].中国计划生育和妇产科,2015,(07):0.
LIAO Hong-yu,[J].Chinese Journal of Family Planning & Gynecotokology,2015,(5):0.
[6]康丹阳,杨巧妮,乔宠*.应用血栓弹力图监测不同流产次数的复发性流产患者凝血功能变化情况[J].中国计划生育和妇产科,2017,(2):22.
KANG Dan-yang,YANG Qiao-ni,QIAO Chong*.Application of thrombelastography to monitor the change of coagulation function in patients of recurrent spontaneous abortion in different times[J].Chinese Journal of Family Planning & Gynecotokology,2017,(5):22.
[7]刘素华*,赵阳阳,訾苹苹,等.肝素对复发性流产患者凝血功能、并发症及妊娠结局的影响[J].中国计划生育和妇产科,2017,(5):44.
LIU Su-hua*,ZHAO Yang-yang,ZI Ping-ping,et al.Effect of heparin on coagulation function, complication and pregnancy outcome in patients with recurrent spontaneous abortion[J].Chinese Journal of Family Planning & Gynecotokology,2017,(5):44.
[8]杨纨,王海燕*.多囊卵巢综合征与复发性流产[J].中国计划生育和妇产科,2017,(10):1.
[9]罗云瑶,程冉,许良智*.复发性流产与染色体相关因素的研究进展[J].中国计划生育和妇产科,2017,(10):7.
[10]欧玉华,张建平*.低分子肝素在复发性流产中应用的现状研究[J].中国计划生育和妇产科,2017,(10):10.